One would expect that a systemic vaccine induces a strong systemic IgG/IgA response that protects only once the virus has entered the host, but the finding that infection is strongly reduced in vaccinated people suggests that the immunoglobulins have reached mucosal surfaces for barrier protection. The gene discussed is CD79A; the disease is infection.